Important GLP1-GO is not a medical device and does not diagnose, treat, cure, or prevent any medical condition
The American Diabetes Association (ADA) and American College of Cardiology (ACC) recommend a multifaceted approach that extends beyond glycemic control
The rats were divided into 3 groups: topical TCC (blue copper peptide), topical TCC carrier (hydroxypropyl methylcellulose), and no treatment (control)
These include pancreatitis, gallbladder problems, and kidney problems
Weve had degeneration of the axons, and of course this mouse is never going to see again
A different analysis that included people stopping various weight-loss medications (including liraglutide, semaglutide, tirzepatide) found that, regardless of the medication, people tend to start regaining weight around 8 weeks after stopping